SSH -NASHVILLE — History
CCN 442011 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$51M
Latest Revenue (FY2022)
+11.7%
Revenue CAGR (3yr)
-7.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $41M | $44M | $51M | +17.1% | +11.7% |
| Operating Expenses | $35M | $46M | $55M | +18.2% | +24.3% |
| Operating Margin | 13.2% | -6.4% | -7.4% | -15.6% | +0.0% |
| Net Income | $5M | $-3M | $-4M | -35.4% | +0.0% |
| Licensed Beds | 70 | 80 | 100 | +25.0% | +19.5% |
| Total Patient Days | 22,412 | 23,549 | 27,082 | +15.0% | +9.9% |
| Medicare Day % | 30% | 27% | 32% | +20.7% | +3.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +24.9% ($41M → $51M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+11.7%
This Hospital
+7.6%
State Avg
Latest Margin
-7.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $56M | -17.7% |
| FY2024 (proj) | $61M | -28.0% |
| FY2025 (proj) | $66M | -38.3% |